Gilead Sciences, Inc. ( GILD) - Key Metrics

GILD Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $6.38 $1.76 $2.68 $2.68
2025Q3 $6.25 $2.46 $3.30 $3.19
2025Q2 $5.69 $1.57 $0.66 $0.58
2025Q1 $5.35 $1.06 $1.41 $1.33

GILD Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 44.95% 17.46
2025Q3 32.93% 11.30
2025Q2 50.71% 17.61
2025Q1 76.81% 26.54

GILD Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 1.40% ?
2025Q4 2.05% 0.64%
2025Q3 2.87% 0.73%
2025Q2 0.52% 0.72%
2025Q1 1.18% 0.72%

GILD

List: Contenders

Price: $128.99

52 week price:
104.46
157.29

Dividend Yield: 2.47%

5-year range yield:
2.14%
5.18%

Forward Dividend Yield: 2.54%

Payout Ratio: 375.61%

Payout Ratio Range:
-69.01%
24533.33%

Dividend Per Share: 3.19 USD

Earnings Per Share: 7.34 USD

P/E Ratio: 18.13

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.7 million

Ebitda: 2.4 billion

Market Capitalization: 160.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 12

DGR3: 2.70%

DGR5: 3.56%

DGR10: 30.00%

Links: